Navigation Links
Kinetiq Announces the Addition of Key Executives; Two Will Speak at Upcoming Clinical Research Conferences

Kinetiq, a new division of Quorum Review IRB with a focus on providing consulting and IT services, is proud to announce the completion of its executive leadership team.

“I’m thrilled with the addition of our new leadership,” says Cami Gearhart, CEO. “Each of our new executives brings the talent and experience needed to keep Kinetiq at the forefront of providing services to the global clinical research community.”

Mitchell Parrish joins Kinetiq as Vice President of Legal Affairs. Mr. Parrish has served in both in-house and outside counsel roles focused on life sciences and human subject protection; he has been a consultant to the National Cancer Institute and an attorney with the global law firm K&L Gates. Mr. Parrish is a frequent speaker on clinical trial topics and is a published author on regulatory affairs. He is a member of the bar associations in Washington and Oregon, a member of the Regulatory Affairs Professionals Society, a Certified IRB Professional and holds Regulatory Affairs Certification. Mr. Parrish will co-present along with Dr. Owen Garrick, CEO of Bridge Clinical, at the ACRP Annual Meeting in a panel session titled “Social Media in Clinical Trial Patient Recruitment” on Saturday, April 16.

James Riddle joins Kinetiq as Vice President of Client Services. Prior to joining Kinetiq, Mr. Riddle served as Assistant Director at the Fred Hutchinson Cancer Research Center, one of the nation’s largest independent cancer research centers, and he has over 15 years of experience leading private and academic human subject protection programs. Mr. Riddle has served as a site visitor for the Association for Accreditation of Human Subject Protection Programs, is a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research, has served on the Board of the Northwest Association for Biomedical Research and is a Certified IRB Professional. Mr. Riddle will present at the AAHRPP Annual Conference in a breakout session titled “Single IRB Review: Retooling Your Staff” on Wednesday, April 20.

Kyle Maeda has been selected to be the Vice President of Information Technology for Kinetiq. Mr. Maeda brings over 20 years of experience improving the performance of global technology firms. As a senior executive, Mr. Maeda has solved business transformation challenges in multiple industries focusing on global strategy and delivery excellence. Most recently, Mr. Maeda was principal of a cross-industry management consulting practice focused on the innovative use of technology. He also led the global IT team for a Fortune 200 manufacturing firm and provided mergers and acquisitions as well as technology leadership for a Global 1000 wireless carrier.

“The diverse leadership experience and strategic excellence of these executives will quickly position Kinetiq for growth as a leader in clinical trials consulting and software solutions,” said Tom Favillo, President and COO of Quorum.

Find out more about Kinetiq services at

About Kinetiq
Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subjects protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies—as well as others around the world—to develop contemporary approaches to a changing landscape.

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. Opal Kelly Announces ZEM5305 Integration Module with Altera Cyclone V E and FrontPanel SDK
2. EY Announces Brian Meshkin, CEO at Proove Biosciences, as EY Entrepreneur Of The Year® 2016 Orange County Semifinalist for the 2nd Year in a Row
3. Genedata Announces the Release of Genedata Bioprocess - New Workflow Platform for Biopharmaceutical Development
4. SPIE Announces 2016 Award Recipients for Achievements in Optics and Photonics
5. DELVE HEALTH Announces New Advisory Board
6. CSM Announces Promotion of Brian Swites to President
7. Rocky Mountain Biologicals Announces Water for Injection (WFI) Manufacturing Facility in West Jordan, Utah
8. Temarry Recycling Announces That Exporting Hazardous Waste Eliminates Biennial Reporting Requirement
9. Charm Sciences Announces FDA Release of 2400 Forms for Charm Peel Plate AC and EC Microbial Tests
10. CfPIE Announces New Training Course on the Regulated Medical Marijuana Business
11. Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System
Post Your Comments:
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid ... pleased to announce that it has moved into a new, 5000 sqft, purpose-built, ... the new facility demonstrates the company's continuous commitment to quality research and service ...
(Date:9/24/2019)... ... 2019 , ... Drug resistance has been declared as one of the biggest ... one of the most serious concerns. Hong Kong cannot be spared from the worsening ... or a seven-fold of the figure in 2007 – the year the disease became ...
(Date:9/24/2019)... ... ... In the past three years, the National Science Foundation (NSF) has awarded ... of Mines & Technology that expands human understanding of the microbial world. The ... and yet strong layer which is commonly known as a biofilm. , The broad ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester ... today that the U.S. Patent and Trademark Office (USPTO) and European Patent Office ... class recommendations for hypertension treatment. , The patent applies to Geneticure’s first ...
Breaking Biology Technology:
(Date:10/3/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... stem cell treatment of knee osteoarthritis . The successful enrollment comes only a little ... Biopharma. , PSC CEO, Michael Dale, stated, “We are proud that as we celebrate ...
(Date:9/30/2019)... ALTO, Calif. (PRWEB) , ... September 30, 2019 ... ... public interest organization focused on molecular manufacturing and other transformative technologies, announced the ... categories, one for Experiment and the other for Theory in nanotechnology/molecular manufacturing. , ...
(Date:9/30/2019)... ... September 30, 2019 , ... As human induced pluripotent stem cells (hiPSCs) ... the development and diseases of the human heart, there is an increasing need for ... muscle cells to be clearly and easily recorded. A study released today in STEM ...
Breaking Biology News(10 mins):